May 1, 2018 / 9:05 PM / 3 months ago

BRIEF-Trevena Inc And Jiangsu Nhwa Pharmaceutical Announce License Agreement For Oliceridine In China

May 1 (Reuters) - Jiangsu Nhwa Pharmaceutical Co Ltd :

* TREVENA INC. AND JIANGSU NHWA PHARMACEUTICAL CO. LTD ANNOUNCE LICENSE AGREEMENT FOR OLICERIDINE IN CHINA

* TREVENA INC - TREVENA TO RECEIVE UPFRONT AND MILESTONE PAYMENTS AND ROYALTIES

* TREVENA INC - NHWA GRANTED A LICENSE TO DEVELOP, MANUFACTURE, AND COMMERCIALIZE OLICERIDINE IN CHINA

* TREVENA INC - TREVENA EXPECTS TO RECEIVE NEAR-TERM PAYMENTS OF $5.5 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below